CSIMarket Company Name, Ticker, Industry, else..
 
Day One Biopharmaceuticals Inc   (DAWN)
Other Ticker:  
 
 
Price: $15.3200 $-1.10 -6.699%
Day's High: $16.57 Week Perf: -16.51 %
Day's Low: $ 15.11 30 Day Perf: -17.59 %
Volume (M): 1,216 52 Wk High: $ 28.35
Volume (M$): $ 18,635 52 Wk Avg: $17.91
Open: $16.57 52 Wk Low: $5.44



 Market Capitalization (Millions $) 1,004
 Shares Outstanding (Millions) 66
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -142
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Day One Biopharmaceuticals Inc


   Company Address: 2000 Sierra Point Parkway Brisbane 94005 CA
   Company Phone Number: 484-0899   Stock Exchange / Ticker: NASDAQ DAWN
   DAWN is expected to report next financial results on May 11, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Alcoa Corp

Loss higher than a year prior at the Alcoa Corp in the most recent fiscal period

Weak orders caused growth in losses for the fiscal three months ending December 31 2022, Alcoa Corps' net deficit per share increased to $-2.22 from $-2.06 where Sales dropped by -20.269 % to $2.66 billions from $3.34 billions a year prior.

Goliath Film And Media Holdings

Goliath Film And Media Holdings, reduction in the corporate results during the third quarter of 2023 earnings season

Trailing the big players in the Broadcasting Media & Cable TV sector, a few overlooked businesses are publishing the respective earnings. Goliath Film And Media Holdings told it has reported operating deficit of $-0.007297 millions, for the third quarter of 2023.

Pure Bioscience Inc

Slight -4.567 %, Sales slide at the company in the fiscal second quarter of 2023

For the fiscal time-frame ending January 31 2023 company lost money of $-0.01 per share compare to $-0.01 a year prior and from $-0.01 per share from the prior financial reporting period.

Sales contracted by -4.567 % to $0.40 millions from $0.42 millions in the similar financial reporting period a year prior and sequentially Sales fell by -15.711 % from $0.47 millions.

Ladrx Corporation

The ascending company from the Biotechnology & Pharmaceuticals sector the LADX reported the fiscal period ending fourth quarter of 2022, results

Trailing the leaders in the Biotechnology & Pharmaceuticals industry, a number of lesser known businesses are coming in with their earnings. LADX told it has clinched operating shortfall of $-0.712711 millions, for the fourth quarter of 2022.

Sonim Technologies Inc

Robust Sales and smaller losess at the company in the October to December 31 2022 time-frame

An ordinary Sales advance in the financial time-frame ending December 31 2022, by 51.39 % to $24.12 millions fueled to cut losses to $-0.02 per share, from $-0.18 in similar the reporting period a year before.





 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

 Stocks


Event Calendar

TLS's Profile

Stock Price

TLS's Financials

Business Description

Fundamentals

Charts & Quotes

TLS's News

Suppliers

TLS's Competitors

Customers & Markets

Economic Indicators

TLS's Growth

Company Segments

 Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness
Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

 Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

 News


At a Glance

Stocks

Economy

Industries

Other
Help


Sitemap

Advertise

About us

 Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071